Semaglutide, the active ingredient found in Ozempic and Wegovy, may reduce the risk of Alzheimer’s disease, a new study published Thursday morning finds.
Lilly will launch its Mounjaro obesity drug in Denmark next week, the U.S. drugmaker said on Thursday, bringing competition ...
Eli Lilly (NYSE:LLY) is reportedly preparing to launch its drug Mounjaro in Denmark, the home country of its leading rival in the weight-loss drug market, Novo Nordisk (NVO). Lilly (LLY) plans to ...